Study: CMV Accelerates Aging Effect on the Immune System; polyDNA Recommends Gene-Eden-VIR to Boost the Immune System against the Cytomegalovirus

“Persistent Cytomegalovirus (CMV) infection is associated with accelerated aging of the immune system and with several age-related diseases,” according to a study published in Experimental Gerontology on April 2, 2014 (1). polyDNA recommends that seniors take Gene-Eden-VIR, which was designed to boost the immune system against the latent human cytomegalovirus.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Since CMV has the potential to really harm an older person, those who want to stay healthy as they age should talk to their doctor about Gene-Eden-VIR. - Mike Evans, polyDNA

Rochester, NY (PRWEB) April 16, 2014

As people age, their immune systems become less efficient. This is a normal process called “Immunosenescence.” It is characterized by “impaired protective immunity and decreased efficacy of vaccines (1).” Research shows that the human cytomegalovirus (CMV) can accelerate and worsen this natural decline of the immune system (1). Another study showed how the CMV accelerates the natural deterioration of the immune system. (See Immunity & Ageing, from October 31, 2012) (2). polyDNA recommends that people over the age of 55 talk to their doctors about Gene-Eden-VIR. This natural antiviral was shown to reduce symptoms of a CMV infection in a post-marketing clinical study that followed FDA guidelines.

A persistent infection with the cytomegalovirus harms certain immune cells and reduces their numbers. As people age, a CMV infection becomes more likely. Time and the CMV therefore become two of the greatest enemies faced by the immune system. As researchers noted “persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs.-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates ‘immunosenescence’ (2).”

Interestingly, many doctors underestimate the impact of CMV on an older person’s health. Researchers wrote that there was a “significant underestimation of the effect of CMV infection on chronic disease and mortality risk (2).” Moreover, it was found that CMV produces an “increased risk for all-cause mortality. The impact of CMV was largely explained by an increase in cardiovascular (CVD) deaths. CMV’s main impact was seen in individuals aged 55-75 (2).”

“Since CMV has the potential to really harm an older person, those who want to stay healthy as they age should talk to their doctor about Gene-Eden-VIR. This natural antiviral was shown to reduce CMV symptoms in a post-marketing clinical study.” - Mike Evans, polyDNA

In a post marketing clinical study published on August 12, 2013 in the medical journal Pharmacology & Pharmacy in a special edition on Advances in Antiviral Drugs, researchers showed that Gene-Eden-VIR is safe and effective (3). Additionally, up to 70% of those studied reported a decrease in symptoms associated with a CMV infection, and users experienced an increase in overall health (3).

Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent herpes virus (3).

Additionally, the CMV virus can cause individuals to feel fatigued. A second clinical study showed that Gene-Eden-VIR decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (4).

To learn more about Gene-Eden-VIR, visit http://www.gene-eden-vir.com.

All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) New advances in CMV and immunosenescence. Published on April 2, 2014.
http://www.ncbi.nlm.nih.gov/pubmed/24703889

(2) CMV and Immunosenescence: from basics to clinics. Published on October 31, 2012.
http://www.ncbi.nlm.nih.gov/pubmed/?term=cmv+and+immunosenescence%3A+from+basics+to+clinics

(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.UzUrbKiSz90

(4) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.UzUrmaiSz90

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.